Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

21 trials with published results (45%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

8.5%

4 terminated out of 47 trials

Success Rate

87.1%

+0.6% vs benchmark

Late-Stage Pipeline

49%

23 trials in Phase 3/4

Results Transparency

78%

21 of 27 completed with results

Key Signals

21 with results87% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (2)
P 1 (6)
P 2 (3)
P 3 (21)
P 4 (2)

Trial Status

Completed27
Active Not Recruiting4
Not Yet Recruiting4
Recruiting4
Terminated4
Unknown2

Trial Success Rate

87.1%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (47)

Showing 20 of 20 trials
NCT06386419Phase 4Completed

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT04998201Phase 2CompletedPrimary

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

NCT07206472Active Not Recruiting

A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

NCT07495514Phase 1Enrolling By InvitationPrimary

A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers

NCT04579367Active Not Recruiting

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT07474649Phase 3Not Yet Recruiting

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

NCT07444762Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

NCT06686615Recruiting

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT07409636Completed

A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

NCT07394517Not ApplicableNot Yet RecruitingPrimary

ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3

NCT05399992Active Not Recruiting

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

NCT06497127Phase 2Active Not RecruitingPrimary

A Study in Patients With Mixed Dyslipidemia

NCT07319559Phase 1CompletedPrimary

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

NCT07152873Phase 1Not Yet RecruitingPrimary

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

NCT04832971Phase 2CompletedPrimary

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

NCT06314919Recruiting

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

NCT06976489Phase 1Not Yet RecruitingPrimary

The Food Effect on PK Characteristics and Safety Profiles of PA-111

NCT06932705Phase 1RecruitingPrimary

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

NCT05400317Phase 3RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of AD-218

NCT05118230Completed

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Scroll to load more

Research Network

Activity Timeline